{
    "organizations": [],
    "uuid": "4b9b81e3a097515c8d11f397f54c6993851c4976",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-zealand-and-roche-diabetes-care-en/brief-zealand-and-roche-diabetes-care-enter-phase-3-study-collaboration-for-treatment-of-congenital-hyperinsulinism-with-dasiglucagon-idUSFWN1RO0P6",
    "ord_in_thread": 0,
    "title": "BRIEF-Zealand And Roche Diabetes Care Enter Phase 3 Study Collaboration For Treatment Of Congenital Hyperinsulinism With Dasiglucagon",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 11 (Reuters) - Zealand Pharma A/S - Co Is Responsible For Conducting Phase 3 Trials, While Roche Diabetes Care Provides Its Accu :\n* ZEALAND AND ROCHE DIABETES CARE ENTER PHASE 3 STUDY COLLABORATION FOR TREATMENT OF CONGENITAL HYPERINSULINISM WITH DASIGLUCAGON\n* SURGICAL TREATMENT FOR CHILDREN WITH CHI * PHASE 3 TRIALS OF DASIGLUCAGON ARE SET TO START IN SECOND HALF OF 2018\n* CHEK COMBO PUMP SYSTEM FOR STUDY Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-11T20:07:00.000+03:00",
    "crawled": "2018-04-12T14:11:01.019+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "zealand",
        "pharma",
        "co",
        "responsible",
        "conducting",
        "phase",
        "trial",
        "roche",
        "diabetes",
        "care",
        "provides",
        "accu",
        "zealand",
        "roche",
        "diabetes",
        "care",
        "enter",
        "phase",
        "study",
        "collaboration",
        "treatment",
        "congenital",
        "hyperinsulinism",
        "dasiglucagon",
        "surgical",
        "treatment",
        "child",
        "chi",
        "phase",
        "trial",
        "dasiglucagon",
        "set",
        "start",
        "second",
        "half",
        "chek",
        "combo",
        "pump",
        "system",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}